CDTX
Price
$73.49
Change
-$1.98 (-2.62%)
Updated
Sep 23 closing price
Capitalization
1.86B
KPRX
Price
$2.54
Change
-$0.07 (-2.68%)
Updated
Sep 23 closing price
Capitalization
8.72M
Interact to see
Advertisement

CDTX vs KPRX

Header iconCDTX vs KPRX Comparison
Open Charts CDTX vs KPRXBanner chart's image
Cidara Therapeutics
Price$73.49
Change-$1.98 (-2.62%)
Volume$737.68K
Capitalization1.86B
Kiora Pharmaceuticals
Price$2.54
Change-$0.07 (-2.68%)
Volume$32.71K
Capitalization8.72M
CDTX vs KPRX Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. KPRX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and KPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CDTX: $73.49 vs. KPRX: $2.54)
Brand notoriety: CDTX and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 135% vs. KPRX: 56%
Market capitalization -- CDTX: $1.86B vs. KPRX: $8.72M
CDTX [@Biotechnology] is valued at $1.86B. KPRX’s [@Biotechnology] market capitalization is $8.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileKPRX’s FA Score has 2 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • KPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, KPRX is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while KPRX’s TA Score has 3 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 4 bearish.
  • KPRX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than KPRX.

Price Growth

CDTX (@Biotechnology) experienced а +13.57% price change this week, while KPRX (@Biotechnology) price change was -4.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.86B) has a higher market cap than KPRX($8.72M). CDTX YTD gains are higher at: 173.400 vs. KPRX (-23.030). KPRX has higher annual earnings (EBITDA): -9.41M vs. CDTX (-208.92M). CDTX has more cash in the bank: 511M vs. KPRX (20.7M). KPRX has less debt than CDTX: KPRX (430K) vs CDTX (2.33M). CDTX (0) and KPRX (0) have equivalent revenues.
CDTXKPRXCDTX / KPRX
Capitalization1.86B8.72M21,374%
EBITDA-208.92M-9.41M2,221%
Gain YTD173.400-23.030-753%
P/E RatioN/A3.67-
Revenue00-
Total Cash511M20.7M2,469%
Total Debt2.33M430K543%
FUNDAMENTALS RATINGS
CDTX vs KPRX: Fundamental Ratings
CDTX
KPRX
OUTLOOK RATING
1..100
135
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3483
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KPRX's Valuation (18) in the Pharmaceuticals Other industry is significantly better than the same rating for CDTX (85) in the Biotechnology industry. This means that KPRX’s stock grew significantly faster than CDTX’s over the last 12 months.

CDTX's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as KPRX (100) in the Pharmaceuticals Other industry. This means that CDTX’s stock grew similarly to KPRX’s over the last 12 months.

CDTX's SMR Rating (97) in the Biotechnology industry is in the same range as KPRX (97) in the Pharmaceuticals Other industry. This means that CDTX’s stock grew similarly to KPRX’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for KPRX (83) in the Pharmaceuticals Other industry. This means that CDTX’s stock grew somewhat faster than KPRX’s over the last 12 months.

KPRX's P/E Growth Rating (1) in the Pharmaceuticals Other industry is significantly better than the same rating for CDTX (100) in the Biotechnology industry. This means that KPRX’s stock grew significantly faster than CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXKPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 28 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVUIX40.690.01
+0.02%
NAA SMid Cap Value Institutional
OPMIX35.92-0.08
-0.22%
Invesco Main Street Mid Cap R6
RRCOX64.82-0.37
-0.57%
T. Rowe Price U.S. Equity Research R
BMIDX18.28-0.12
-0.65%
Brown Advisory Mid-Cap Growth Investor
ESGCX20.08-0.15
-0.74%
Mirova Global Megatrends C

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with NBY. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.62%
NBY - CDTX
93%
Closely correlated
+1.42%
NCNA - CDTX
93%
Closely correlated
-2.99%
TAOX - CDTX
93%
Closely correlated
-2.90%
BPTSY - CDTX
92%
Closely correlated
N/A
KPRX - CDTX
90%
Closely correlated
-2.68%
More

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if KPRX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-2.68%
NCNA - KPRX
90%
Closely correlated
-2.99%
RNAC - KPRX
89%
Closely correlated
-2.29%
NBY - KPRX
89%
Closely correlated
+1.42%
ALLR - KPRX
86%
Closely correlated
-10.11%
TNXP - KPRX
84%
Closely correlated
-5.56%
More